This course has expired. View available courses.
Cardiovascular, Medication Management
Elecsys proBNP II and the evolving role of NT-proBNP testing in the diagnosis of heart failure
This educational activity was developed by MdBriefCase, with funding from Roche Diagnostics.
DURATION
15 min
PROFESSION
Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-02-15
N-terminal pro B-type natriuretic peptide (NT-proBNP) has demonstrated diagnostic and prognostic value in heart failure (HF). Clinical guidelines, including those of the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand, recommend measuring NT-proBNP in patients with suspected acute or chronic HF, when the diagnosis is uncertain, in order to expedite either early diagnosis or early exclusion of HF. Very high NT-proBNP concentration carries a poor prognosis and changes in NT-proBNP correlate with clinical course, facilitating individualised clinical management.
This educational activity was developed by MdBriefCase, with funding from Roche Diagnostics.
Faculty
Professor Andrew Sindone, B. Med (Hons), MD, FRACP, FCSANZ, FNHFA
Learning objectives
After reading this product brief, cardiologists should improve their:
- Appreciation of the diagnostic value of NT-pro BNP testing in acute and chronic HF
- Recognition of the prognostic role of NT-proBNP concentrations in a variety of clinical scenarios
- Understanding of the role of NT-pro BNP testing in optimising discharge planning of patients with HF
#
of credits: 0
Duration: 15 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
15 min
Duration
Specialist
Profession
0
# of credits
Learning Objectives
After reading this product brief, cardiologists should improve their:
- Appreciation of the diagnostic value of NT-pro BNP testing in acute and chronic HF
- Recognition of the prognostic role of NT-proBNP concentrations in a variety of clinical scenarios
- Understanding of the role of NT-pro BNP testing in optimising discharge planning of patients with HF
Unaccredited
ACCREDITATION
Cardiovascular, Medication Management
Learning Category
General
Topic
0
Price
2023-02-15
Expiry Date
AUS
Region/Language
Course Description
N-terminal pro B-type natriuretic peptide (NT-proBNP) has demonstrated diagnostic and prognostic value in heart failure (HF). Clinical guidelines, including those of the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand, recommend measuring NT-proBNP in patients with suspected acute or chronic HF, when the diagnosis is uncertain, in order to expedite either early diagnosis or early exclusion of HF. Very high NT-proBNP concentration carries a poor prognosis and changes in NT-proBNP correlate with clinical course, facilitating individualised clinical management.
This educational activity was developed by MdBriefCase, with funding from Roche Diagnostics.
Faculty
Professor Andrew Sindone, B. Med (Hons), MD, FRACP, FCSANZ, FNHFA
Accreditation
15 min
Duration
0
Price
0
# of credits
